Sign in or Register   Sign in or Register
  |  

Mouse Anti-HMMR Recombinant Antibody (2F2C9) (CBMAB-R0267-CN)

This product is a Mouse antibody that recognizes HMMR. The antibody 2F2C9 can be used for immunoassay techniques such as: WB, FC, ELISA, CyTOF.
See all HMMR antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
2F2C9
Antibody Isotype
IgG1
Application
WB, FC, ELISA, CyTOF

Basic Information

Immunogen
Purified recombinant fragment of human CD168 (aa. 306-497) expressed in E. Coli
Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Target

Full Name
hyaluronan mediated motility receptor
Introduction
The protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Dec 2008]
Entrez Gene ID
3161
UniProt ID
O75330
Alternative Names
Hyaluronan Mediated Motility Receptor; Intracellular Hyaluronic Acid-Binding Protein; Receptor For Hyaluronan-Mediated Motility; IHABP; RHAMM; Hyaluronan-Mediated Motility Receptor (RHAMM); Hyaluronan-Mediated Motility Receptor; CD168 Antigen; CD168;
Function
Receptor for hyaluronic acid (HA) (By similarity).

Involved in cell motility (By similarity).

When hyaluronan binds to HMMR, the phosphorylation of a number of proteins, including PTK2/FAK1 oCcurs. May also be involved in cellular transformation and metastasis formation, and in regulating extracellular-regulated kinase (ERK) activity. May act as a regulator of adipogenisis (By similarity).
Biological Process
Cytoplasm; Spindle; Cell surface

Tarullo, S. E., He, Y., Daughters, C., Knutson, T. P., Henzler, C. M., Price, M. A., ... & Nelson, A. C. (2023). Receptor for hyaluronan‐mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. The Journal of Pathology.

Mei, L. (2022). Hyaluronan mediated motility receptor regulates daughter cell size control pathways during mitosis (Doctoral dissertation, University of British Columbia).

Sun, H., Ma, L., & Chen, J. (2021). Hyaluronan-mediated motility receptor expression functions as a prognostic biomarker in uterine carcinosarcoma based on bioinformatics analysis. Journal of International Medical Research, 49(6), 03000605211021043.

Tang, Y. P., Yin, Y. X., Xie, M. Z., Liang, X. Q., Li, J. L., Li, K. Z., & Hu, B. L. (2021). Systematic analysis of the clinical significance of hyaluronan-mediated motility receptor in colorectal cancer. Frontiers in Molecular Biosciences, 8, 733271.

Lu, T., Zheng, Y., Gong, X., Lv, Q., Chen, J., Tu, Z., ... & Li, J. (2021). High expression of hyaluronan-mediated motility receptor predicts adverse outcomes: a potential therapeutic target for head and neck squamous cell carcinoma. Frontiers in Oncology, 11, 608842.

Kang, H. G., Kim, W. J., Kang, H. G., Chun, K. H., & Kim, S. J. (2020). Galectin-3 interacts with C/EBPβ and upregulates hyaluronan-mediated motility receptor expression in gastric cancer. Molecular Cancer Research, 18(3), 403-413.

He, Z., Mei, L., Connell, M., & Maxwell, C. A. (2020). Hyaluronan mediated motility receptor (HMMR) encodes an evolutionarily conserved homeostasis, mitosis, and meiosis regulator rather than a hyaluronan receptor. Cells, 9(4), 819.

Ye, S., Liu, Y., Fuller, A. M., Katti, R., Ciotti, G. E., Chor, S., ... & Eisinger-Mathason, T. K. (2020). TGFβ and hippo pathways cooperate to enhance sarcomagenesis and metastasis through the hyaluronan-mediated motility receptor (HMMR). Molecular Cancer Research, 18(4), 560-573.

He, F., Zu, D., Lan, C., Niu, J., & Nie, X. (2020). hsa‑microRNA‑411‑5p regulates proliferation, migration and invasion by targeting the hyaluronan mediated motility receptor in ovarian cancer. Experimental and Therapeutic Medicine, 20(3), 1899-1906.

Zhang, H., Ren, L., Ding, Y., Li, F., Chen, X., Ouyang, Y., ... & Zhang, D. (2019). Hyaluronan‐mediated motility receptor confers resistance to chemotherapy via TGFβ/Smad2‐induced epithelial‐mesenchymal transition in gastric cancer. The FASEB Journal, 33(5), 6365-6377.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-HMMR Recombinant Antibody (2F2C9)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare